SCHEMBL8683223

SCHEMBL8683223

CCCCOC(=O)OC1CCC[N]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
ATM Q13315 1/20 0.37
TSHR P16473 3/20 0.35
HPGD P15428 1/20 0.35
NAAA Q02083 3/20 0.34
HCAR2 Q8TDS4 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPK1 P28482 2/20 0.32
KDM4E B2RXH2 1/20 0.32
EPHX2 P34913 1/20 0.32
ESR1 P03372 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
NR1H2 P55055 1/20 0.31
RNASEL Q05823 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8701965 0.95 ALDH1A1 (0.38) ALDH1A1ATMTSHRHPGDNAAA
SCHEMBL8681136 0.95 NAAA (0.39) ALDH1A1TSHRNAAAHCAR2L3MBTL1
SCHEMBL8680816 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8686113 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8680974 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8681070 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8680776 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8680921 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8683097 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA
SCHEMBL8682074 0.94 NAAA (0.41) ALDH1A1TSHRNAAAHCAR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed